ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,525Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 682

$1.29M Total Retail Price of All Prescriptions

Rank: 49 out of 682

725 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 725 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 725 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 17,606 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,350 845 S3 1 1
LISINOPRIL 657 519 2 2
OMEPRAZOLE 625 490 3 5
SIMVASTATIN 602 457 4 4
FUROSEMIDE 590 458 5 7
LEVOTHYROXINE SODIUM 560 427 6 3
PRAVASTATIN SODIUM 495 343 7 15
GABAPENTIN 476 330 8 9
AMLODIPINE BESYLATE 411 346 9 6
CITALOPRAM HBR 411 325 9 17
WARFARIN SODIUM 396 325 11 13
METFORMIN HCL ER 343 263 12 68
POTASSIUM CHLORIDE 337 270 13 14
RANITIDINE HCL 301 205 14 28
CLOPIDOGREL 296 241 15 25
HYDROCHLOROTHIAZIDE 292 257 16 12
ATORVASTATIN CALCIUM 274 230 17 11
METOPROLOL SUCCINATE 274 200 17 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 269 203 19 34
SERTRALINE HCL 268 189 20 24
DONEPEZIL HCL 268 255 20 30
METOPROLOL TARTRATE 261 217 22 10
JANUVIA 246 197 23 62
NEXIUM 237 159 24 19
PANTOPRAZOLE SODIUM 234 200 25 29
RISPERIDONE 230 229 26 82
GLIMEPIRIDE 229 180 27 43
METFORMIN HCL 220 163 28 8
PLAVIX 205 157 29 35
TAMSULOSIN HCL 205 190 29 33
ATENOLOL 203 170 31 18
CRESTOR 191 147 32 22
PROMETHAZINE HCL 179 59 R 33 54
CARVEDILOL 176 149 34 23
TRAZODONE HCL 159 97 35 38
PAROXETINE HCL 156 137 36 53
NAMENDA 154 142 37 41
AZITHROMYCIN 146 119 38 39
PROAIR HFA 145 80 39 45
MELOXICAM 142 103 40 27
LOSARTAN-HYDROCHLOROTHIAZIDE 141 113 41 56
SULFAMETHOXAZOLE-TRIMETHOPRIM 138 119 42 103
ZOLPIDEM TARTRATE 133 77 43 21
LOSARTAN POTASSIUM 132 116 44 20
ALLOPURINOL 127 100 45 32
ZETIA 127 91 45 69
DIGOXIN 126 126 47 46
SPIRIVA 121 101 48 49
NABUMETONE 120 44 49 227
POLYETHYLENE GLYCOL 3350 119 98 50 44
QUETIAPINE FUMARATE 119 77 50 87
AMOX TR-POTASSIUM CLAVULANATE 119 90 50 110
TIZANIDINE HCL 114 53 53 83
ALENDRONATE SODIUM 113 83 54 37
DIOVAN 110 67 55 42
ADVAIR DISKUS 102 84 56 47
MIRTAZAPINE 102 89 56 52
ISOSORBIDE MONONITRATE ER 101 80 58 31
LANTUS 100 50 59 55
METHYLPREDNISOLONE 97 60 60 127
TRIAMTERENE-HCTZ 92 72 61 57
ALPRAZOLAM 92 52 61 90
DICLOFENAC SODIUM 92 75 61 107
INSULIN SYRINGE 89 57 64 75
FLUOXETINE HCL 89 45 64 60
NYSTATIN 87 69 66 95
CEFDINIR 87 72 66 157
SYNTHROID 84 77 68 59
CIPROFLOXACIN HCL 83 67 69 58
NORTRIPTYLINE HCL 81 54 70 263
AMITRIPTYLINE HCL 81 50 R 70 50
ROPINIROLE HCL 80 45 72 71
CYMBALTA 79 49 73 51
NITROFURANTOIN 75 64 74 233
SPIRONOLACTONE 74 58 75 64
FENTANYL 73 39 S2 76 86
ENALAPRIL MALEATE 73 65 76 91
TRAMADOL HCL 72 55 78 26
ESCITALOPRAM OXALATE 72 34 78 73
TRIAMCINOLONE ACETONIDE 71 49 80 149
CARBIDOPA-LEVODOPA 69 66 81 121
GLIPIZIDE XL 68 67 82 181
FLUTICASONE PROPIONATE 68 52 82 36
VYTORIN 67 54 84 145
PREDNISONE 65 54 85 40
ESTRADIOL 65 57 R 85 152
DILTIAZEM ER 63 63 87 136
PREMARIN 63 34 R 87 132
ACTOS 63 45 87 151
NAPROXEN 62 48 90 97
VENLAFAXINE HCL ER 62 54 90 119
EVISTA 61 61 92 135
NOVOLIN R 59 44 93 167
OXYCODONE HCL-ACETAMINOPHEN 59 32 S2 93 98
DIVALPROEX SODIUM 59 40 93 84
HYDROXYZINE HCL 56 32 R 96 187
DILTIAZEM 24HR CD 56 38 96 123
KLOR-CON M20 56 31 96 67
TOPIRAMATE 56 12 96 150
CELEBREX 55 44 100 80
AVODART 54 53 101 211
PHENYTOIN SODIUM EXTENDED 53 38 102 140
LANSOPRAZOLE 53 49 102 85
GLIPIZIDE 52 41 104 61
PRIMIDONE 51 38 105 228
MECLIZINE HCL 51 39 105 124
SYMBICORT 51 31 105 117
LYRICA 51 20 105 78
GLIPIZIDE ER 50 33 109 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.